Dopamine agonists act directly on the dopamine receptors and mimic dopamine's effect. Dopamine agonists have two subclasses: ... Dopamine antagonist Dopamine reuptake inhibitor Receptor agonist GABA receptor agonist Dopaminergic Serotonin agonist ... A dopamine agonist (DA) is a compound that activates dopamine receptors. There are two families of dopamine receptors, D2-like ... Since ergot-dopamine agonist have antihypertensive qualities it is wise to monitor blood pressure when using dopamine agonists ...
D2-receptor agonists, D3 receptor agonists, D4 receptor agonists, Dopamine receptor modulators, Ergolines, Histamine agonists, ... Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". The Journal ... 2006). "Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy ... This is shorter than most other dopamine agonists. Lisuride has more than 15 known metabolites. Lisuride is described as the ...
"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human ... D1-receptor agonists, D2-receptor agonists, D3 receptor agonists, Ergot alkaloids, GABAA receptor positive allosteric ... DHEC, like other dopamine agonists, aims to mimic the endogenous neurotransmitter and exert an antiparkinsonian effect. Recent ... Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH (October 2009). "A reassessment of risks and benefits of dopamine agonists ...
Alpha-2 adrenergic receptor agonists, Allyl compounds, Azepanes, D2-receptor agonists, Dopamine agonists, Thiazoles, All stub ... Talipexole is a D2 dopamine receptor agonist and interacts with both pre- and post-synaptic receptors. It also is an α2- ... Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by ... Page accessed 9 December 2014 Benkert O, Müller-Siecheneder F, Wetzel H (1995). "Dopamine agonists in schizophrenia: a review ...
June 2002). "Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 ... July 2007). "A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients ... Giardina WJ, Williams M (2006). "Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: ... August 2007). "A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in ...
de Paulis T (1983). "3. Antipsychotic Agents and Dopamine Agonists". Annual Reports in Medicinal Chemistry. Academic Press. p. ... Altar CA, Boyar WC, Wasley A, Gerhardt SC, Liebman JM, Wood PL (August 1988). "Dopamine neurochemical profile of atypical ... Flumezapine is an antipsychotic, due to its antagonism of dopamine receptors in the brain. However, like other antipsychotics, ... indicating higher dopamine receptor blockade with less anticholingergic properties. Flumezapine is a thioeno[2,3-b][1,5] ...
Drugs such as bromocriptine act as a dopamine receptor agonist, stimulating the nerves that control movement. Newer synthetic ... Lataste X (February 1984). "The history and pharmacology of dopamine agonists". The Canadian Journal of Neurological Sciences. ... and are either an antagonist of dopamine at the postsynaptic level at the D2 receptor site or an agonist of dopamine at the ... The antagonist or agonist behavior of the ergolines are substrate dependent and mixed agonist/antagonist behaviors of ergoline ...
... (DAR-0100) is a moderately selective full agonist at the dopamine D1 and D5 receptors. It has approximately 10- ... D1-receptor agonists, D2-receptor agonists, D5 receptor agonists, Catechols, Biased ligands, All stub articles, ... Salmi P, Isacson R, Kull B (2004). "Dihydrexidine--the first full dopamine D1 receptor agonist". CNS Drug Rev. 10 (3): 230-242 ... Mailman RB, Nichols DE (1998). "Dopamine D1 receptor agonists as antiparkinson drugs". Trends Pharmacol. Sci. 19 (7): 255-256. ...
Dopamine receptor agonists can also be used. Trihexylphenidyl and amantadine might also be prescribed, especially in cases ... The goal of this medication is to alleviate motor symptoms by increasing the concentration of dopamine in the nervous system. ...
... is a partial agonist of the dopamine D2 receptor. It also interacts with other dopamine receptors and with ... Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". J Pharmacol ... May 2015). "Dopamine agonists for the treatment of cocaine dependence". The Cochrane Database of Systematic Reviews. 2015 (5): ... June 2010). "The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation ...
B. Costall, S. K. Lim, and R. J. Naylor (1981). "Characterisation of the mechanisms by which purported dopamine agonists reduce ... "Dopamine D2 receptor binding sites for agonists. A tetrahedral model." Mol. Pharmacol. 28 391-399. R. A. Wallace, T. Farooqui, ... and the LD50 for dopamine·HCl is 1978 mg/kg (mouse, i.p.). N-methyldopamine Dopamine Hordenine B. A. Clement, C. M. Goff, and T ... In this assay, the ED50 for DMDA was ~ 0.06 μM, and for dopamine it was ~ 1.9 μM. The LD50 for N,N-dimethyldopamine·HCl is ...
November 1985). "Dopamine D2 receptor binding sites for agonists. A tetrahedral model". Molecular Pharmacology. 28 (5): 391-9. ... Burt DR, Creese I, Snyder SH (April 1977). "Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in ... effects due to dopamine D2 receptor antagonism) Confusion in the elderly Drowsiness, dizziness, fatigue, more rarely vertigo ... Known to have effects on serotonin and dopamine receptors. Dry mouth Nausea Respiratory depression in patients under age of two ...
1993). "Medicinal chemistry of imidazoquinolinone dopamine receptor agonists". Drug Design and Discovery. 9 (3-4): 313-22. PMID ... an agonist for the dopamine D2 receptor subtype". European Journal of Pharmacology. 317 (1): 29-38. doi:10.1016/s0014-2999(96) ... is a drug used in scientific research which acts as a potent and reasonably selective agonist of the dopamine receptor D2, with ... Dopamine agonists, All stub articles, Nervous system drug stubs). ...
ISBN 978-0-07-162442-8. Tings T, Trenkwalder C (March 2003). "[When L-Dopa preparations, dopamine agonists or opioids? Therapy ...
Bankowski BJ, Zacur HA (June 2003). "Dopamine agonist therapy for hyperprolactinemia". Clinical Obstetrics and Gynecology. 46 ( ... Rowell PP, Larson BT (July 1999). "Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat ...
It acts on serotonin and dopamine receptors. Specifically, it is an agonist of dopamine D2-like receptors and serotonin 5-HT6 ... 5-HT6 agonists, Abandoned drugs, Dopamine agonists, Ergolines, Prolactin inhibitors, Serotonin receptor antagonists, Sulfamides ... Bankowski BJ, Zacur HA (June 2003). "Dopamine agonist therapy for hyperprolactinemia". Clin Obstet Gynecol. 46 (2): 349-62. doi ...
Webster J (December 1999). "Dopamine agonist therapy in hyperprolactinemia". J Reprod Med. 44 (12 Suppl): 1105-10. PMID ... Dopamine agonists, Ergolines, Prolactin inhibitors, Serotonin receptor antagonists). ... Miller KJ, King A, Demchyshyn L, Niznik H, Teitler M (1992). "Agonist activity of sumatriptan and metergoline at the human 5- ... Metergoline is a ligand of various serotonin and dopamine receptors. Index Nominum 2000: International Drug Directory. Taylor ...
Other dopamine agonists that have been used less commonly to suppress prolactin include dihydroergocryptine, ergoloid, lisuride ... which binds to dopamine receptors. Drugs that block the effects of dopamine at the pituitary or deplete dopamine stores in the ... If the prolactinoma does not initially respond to dopamine agonist therapy, such that prolactin levels are still high or the ... Another option is to consider switching between dopamine agonists. It is possible for the prolactinoma to be resistant to ...
This type of drug is called a dopamine agonist. These drugs shrink the tumor and return prolactin levels to normal in ... Bankowski BJ, Zacur HA (June 2003). "Dopamine agonist therapy for hyperprolactinemia". Clin Obstet Gynecol. 46 (2): 349-62. doi ... Bronstein MD (March 2006). "Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy ... Cabergoline should not be interrupted without consulting a qualified endocrinologist.[citation needed] Other dopamine agonists ...
January 2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". The New England Journal of Medicine. 356 (1): ... January 2007). "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". The New England Journal of ... the serotonin released while consuming activates 5-HT2C receptors on dopamine-producing cells. This halts their dopamine ... When a well-fed worm feels bacteria on its cuticle, dopamine is released, which slows it down; if it is starved, serotonin also ...
2006). "Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy ... Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (January 2007). "Dopamine agonists and the risk of cardiac-valve ... Antonini A, Poewe W (September 2007). "Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease". ... "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". The New England Journal of Medicine. 356 (1 ...
5-HT2B agonists, D2-receptor agonists, D3 receptor agonists, D4 receptor agonists, Dopamine receptor modulators, Equine ... it has high D1 receptor affinity and is one of the most potent D1 receptor agonists of the dopamine receptor agonists that are ... Pergolide acts as an agonist of dopamine D2 and D1 and serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT2C receptors. It may ... Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". The Journal ...
Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (January 2007). "Dopamine agonists and the risk of cardiac-valve ... Reduced prolactin due to ergot alkaloid activity on dopamine receptors in the pituitary is also common in livestock. Reduced ... including dopamine, serotonin and norepinephrine. He also states that the adrenergic blockage by ergopeptines (e.g., ergovaline ...
"Dopamine agonists and the risk of cardiac-valve regurgitation". N. Engl. J. Med. 356 (1): 29-38. doi:10.1056/NEJMoa062222. PMID ... "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". N. Engl. J. Med. 356 (1): 39-46. doi:10.1056/ ... specifically medications containing fenfluramine or dexfenfluramine isomers and dopamine agonists. Other potential causes that ... Alpha/Beta Adrenergic Agonists, Calcium Channel Blockers, Anticoagulants, Cardiovascular, Opioid Analgesics". emedicine. ...
Dopamine agonists are routinely prescribed to women following a stillbirth in the UK under the NHS. After birth, some women may ... Medicines (dopamine agonists) can stop your breasts producing milk. They cause few side effects and may also help you feel ... In the UK dopamine agonists are routinely prescribed following a stillbirth. Pre-eclampsia is a contraindication for ... Dopamine agonists are currently the preferred medication for suppressing lactation, which work by suppressing prolactin ...
ISBN 978-0-85199-723-0. Schade, R.; Andersohn, F.; Suissa, S.; Haverkamp, W.; Garbe, E. (2007). "Dopamine agonists and the risk ...
... is a drug which acts as a dopamine agonist selective for the D1 subtype. Unlike most D1-selective agonists, it shows ... D'Aquila PS, Panin F, Cossu M, Peana AT, Serra G (January 2003). "Dopamine D1 receptor agonists induce penile erections in rats ... Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A (January 2005). "Dopamine agonists suppress ... Beninger RJ, Rolfe NG (December 1995). "Dopamine D1-like receptor agonists impair responding for conditioned reward in rats". ...
D2-receptor agonists, D3 receptor agonists, D4 receptor agonists, Dimethylamino compounds, Dopamine receptor modulators, ... August 2009). "Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine ... Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor". The Journal ... Youssef MA, van Wely M, Hassan MA, Al-Inany HG, Mochtar M, Khattab S, van der Veen F (March 2010). "Can dopamine agonists ...
Excessive prolactin secretion may also occur; this is treated with dopamine agonists such as cabergoline. Radiation therapy has ...
Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". ...